Literature DB >> 34718119

The molecular mosaic of regulated cell death in the cardiovascular system.

Matthew D Martens1, Jason Karch2, Joseph W Gordon3.   

Abstract

Cell death is now understood to be a highly regulated process that contributes to normal development and tissue homeostasis, alongside its role in the etiology of various pathological conditions. Through detailed molecular analysis, we have come to know that all cells do not always die in the same way, and that there are at least 7 processes involved, including: apoptosis, mitochondrial permeability transition (MPT)-driven necrosis, necroptosis, ferroptosis, pyroptosis, parthanatos, and autophagy-mediated cell death. These processes act as pieces in the mosaic of cardiomyocyte cell death, which come together depending on context and stimulus. This review details each individual process, as well as highlights how they come together to produce various cardiac pathologies. By knowing how the pieces go together we can aim towards the development of efficacious therapeutics, which will enable us to prevent cardiomyocyte loss in the face of stress, both reducing mortality and improving quality of life.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiomyocyte; Cell death; Heart; Pathology

Mesh:

Year:  2021        PMID: 34718119     DOI: 10.1016/j.bbadis.2021.166297

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   6.633


  2 in total

1.  MY11 exerts antitumor effects through activation of the NF-κB/PUMA signaling pathway in breast cancer.

Authors:  Qun Ye; Ziwei Jiang; Ying Xie; Yuanhong Xu; Yiyi Ye; Lei Ma; Lixia Pei
Journal:  Invest New Drugs       Date:  2022-06-27       Impact factor: 3.651

2.  Editorial: Insights in cardiovascular therapeutics: 2021 - cell death, cardiovascular injuries, and novel targets of cardiovascular therapeutics.

Authors:  Keman Xu; Mohsin Khan; Jun Yu; Nathaniel W Snyder; Sheng Wu; Roberto I Vazquez-Padron; Hong Wang; Xiaofeng Yang
Journal:  Front Cardiovasc Med       Date:  2022-07-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.